Juergen Ramharter (Jürgen Ramharter)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

High Throughput

Multidrug Resistant

Advanced Non Small Cell Lung Cancer

Molecular Dynamics

Top Venues

Organic process research & development

Journal of medicinal chemistry

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky, Rosa Baumgartinger, Peter Jung, Harald Weinstabl, Juergen Ramharter, Rolf Grempler, Jens Quant, Joerg Rinnenthal, Alejandro Pérez Pitarch, Bojana Golubovic, Daniel Gerlach, Gerd Bader, Kristiane Wetzel, Sebastian Otto, Christian Mandl, Guido Boehmelt, Darryl B McConnell, Norbert Kraut, Patrizia Sini
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules. Molecular cancer therapeutics (2024)
Juergen Ramharter, Michael Kulhanek, Maike Dettling, Gerhard Gmaschitz, Jale Karolyi-Oezguer, Harald Weinstabl, Andreas Gollner
Synthesis of MDM2-p53 Inhibitor BI-0282 via a Dipolar Cycloaddition and Late-Stage Davis-Beirut Reaction. Organic process research & development 26 (8) (2022)
Juergen Ramharter, Dirk Kessler, Peter Ettmayer, Marco H Hofmann, Thomas Gerstberger, Michael Gmachl, Tobias Wunberg, Christiane Kofink, Michael Sanderson, Heribert Arnhof, Gerd Bader, Klaus Rumpel, Andreas Zöphel, Renate Schnitzer, Jark Böttcher, Jonathan C O'Connell, Rachel L Mendes, David Richard, Nikolai Pototschnig, Irene Weiner, Wolfgang Hela, Katja Hauer, Daniela Haering, Lyne Lamarre, Bernhard Wolkerstorfer, Christian Salamon, Patrick Werni, Silvia Munico-Martinez, Reiner Meyer, Matthew D Kennedy, Norbert Kraut, Darryl B McConnell
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS. Journal of medicinal chemistry 64 (10) (2021)